liver and pancreatic – down from an original 10 forms. The MDL court is scheduled to hold a hearing on a motion to exclude plaintiffs' experts arguing the link between ranitidine and cancer next ...

Apotex also said it was recalling ranitidine tablets in the US. The BBC has approached GlaxoSmithKline - original makers of Zantac. The company is reported to have stopped distributing its generic ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...

Zantac’s manufacturers were on a roll ... “[W]e’re out to dominate the entire product category.” (emphasis in original).” Another verdict-inflamer is spoilation, i.e., destroying relevant evidence ...

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.

(WJET/WFXP) — UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level Zantac cases. The lawsuits claimed that the now ...

GSK launched Zantac in 1981 and it was first approved for sale in the US in 1983 as a prescription medication. It went on to become the world's best-selling drug, with annual sales in excess of $1bn.

(RTTNews) - GSK plc (GSK, GSK.L) announced that it has reached agreements with 10 plaintiff firms representing approximately 93% (around 80,000) of the Zantac (ranitidine) product liability cases ...

The Zantac dispute stems from 2019 ... at a proposal to extend the rail line in a less expensive way than the original scheme, according to The Times. Culture Secretary Lisa Nandy said ...